Frontier Capital Management’s Neuronetics STIM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q1
Sell
-253,765
Closed -$1.14M 289
2019
Q4
$1.14M Sell
253,765
-24,808
-9% -$154K 0.01% 272
2019
Q3
$2.31M Buy
278,573
+231,414
+491% +$2.53M 0.02% 269
2019
Q2
$590K Sell
47,159
-19,395
-29% -$274K ﹤0.01% 286
2019
Q1
$1.01M Sell
66,554
-4,267
-6% -$70.6K 0.01% 290
2018
Q4
$1.37M Buy
70,821
+3,128
+5% +$68.6K 0.01% 282
2018
Q3
$2.17M Sell
67,693
-2,064
-3% -$62.7K 0.01% 278
2018
Q2
$1.86M Buy
+69,757
New +$1.9M 0.01% 289

Other funds holding STIM

Frontier Capital Management's STIM Position: Q1 2020 in Review

Frontier Capital Management sold out of Neuronetics (STIM) in Q1 2020, closing a stake of 253,765 shares — an estimated $1.14M sold.

Frontier Capital Management first reported a position in STIM in Q2 2018 and held it in 7 quarters. The position peaked at $2.31M in Q3 2019. 59 funds tracked by Wall St. Rank hold STIM as of Q1 2020.

  • Frontier Capital Management reported no remaining Neuronetics position as of Q1 2020 after selling out during the quarter.
  • Frontier Capital Management sold 253,765 Neuronetics shares in Q1 2020, an estimated $1.14M.
  • Frontier Capital Management first reported a position in Neuronetics in Q2 2018 and held it in 7 quarters.
  • Frontier Capital Management's Neuronetics position peaked at $2.31M in Q3 2019.
  • 59 funds tracked by Wall St. Rank held Neuronetics as of Q1 2020.

Based on Frontier Capital Management's 13F filing for Q1 2020, filed 16 Apr 2020.